Serum Institute of India, IAVI and Merck join forces to develop COVID-19 antibodies

News: Serum Institute of India(SII) and the International AIDS Vaccine Initiative (IAVI) have announced an agreement with pharmaceutical major Merck to develop SARS-CoV-2 neutralising monoclonal antibodies(mAbs). Facts: What are Monoclonal Antibodies? They are man-made proteins that act like human antibodies in the immune system.They are made by cloning a unique white blood cell. Features: Monoclonal antibodies can… Continue reading Serum Institute of India, IAVI and Merck join forces to develop COVID-19 antibodies

Bharat Biotech eyes human monoclonal antibody therapy for Covid-19

News:The Council of Scientific and Industrial Research(CSIR) has sanctioned a project to develop human monoclonal antibodies as a therapy for Covid-19 in the next six months. Facts: The project was approved under CSIR’s New Millennium Indian Technology Leadership Initiative(NMITLI). Aim: To create an alternate therapy by generating highly effective and specific human monoclonal antibodies capable… Continue reading Bharat Biotech eyes human monoclonal antibody therapy for Covid-19

Blog
Academy
Community